Topical kinase inhibitors induce regression of cutaneous squamous cell carcinoma.
Yang X, Daifallah AEM, Shankar S, Beer J, Marshall C, Dentchev T, Seykora F, D'Armas S, Hahn J, Lee V, Sabry HH, Farag AM, Seykora JT.
Yang X, et al.
Exp Dermatol. 2019 May;28(5):609-613. doi: 10.1111/exd.13902. Epub 2019 Mar 13.
Exp Dermatol. 2019.
PMID: 30762245
Free PMC article.